Blood test can detect rejection of transplanted kidney

03/16/2012 | MedCityNews.com

A new molecular blood test uses RNA genetic markers to detect signs of renal failure following a kidney transplant. The test, which can identify kidney failure weeks before clinical symptoms manifest, can serve as a safer alternative to a renal biopsy, which can lead to graft injury or loss or bleeding, according to Quest Diagnostics.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI